Advanced MR Imaging for Brain Cancer
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 135 (estimated)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Other
This trial is looking for adults with brain tumors to see if advanced MRI can help plan better treatment. Participants will undergo MRI scans to identify high-risk areas in their tumors.
You may be able to join if
- I am at least 18 years old.
- I have been diagnosed with a glioma or my tumor may have an IDH mutation.
- I can have radiation therapy.
- I can provide written consent to join the study.
You may not be able to join if
- I have extreme claustrophobia that prevents me from having an MRI.
- I have an allergy to Gd-DTPA dye used in MRIs.
- I have any condition that prevents me from having an MRI, like a pacemaker.
- I am pregnant or nursing.
- I cannot cooperate with the MRI or treatment planning.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThe researchers think that the use of advanced MR imaging may help people with this disease, because it may better predict areas within a malignant glioma (brain tumor) that are at a high risk of recurring. WeThe reserchers are doing this study to see whether this advanced imaging is a safe treatment that causes few or mild side effects in people with brain tumors.
Loading trial locations…
Robert Young, MD
212-639-8196
CONTACT
Sunitha Thakur, PhD
646-608-8262
CONTACT